New Product Briefs: Devices From Covidien, Sorin, Cynosure, Phillips
This article was originally published in The Gray Sheet
Executive Summary
Covidien is gearing-up to sell its new Emprint ablation system for soft tissue. Sorin announced the CE mark for its Crown PRT valve with proprietary anti-calcification treatment. FDA clears Cynosure’s PicoSure to treat acne scars as well as Philips’ portable obstetrics ultrasound.
You may also be interested in...
New Products In Brief
Recent debuts and approvals include Covidien’s AS Meniscal repair device, Medtronic’s Sentrino continuous glucose management system and Blue Belt’s NavioPFS system for partial knee replacement.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.